OSELTAMIVIR PHOSPHATE

Post-LOE

oseltamivir phosphate

Shandong Luoxin Pharmaceutical
ANDAORALCAPSULE
Approved
Jul 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Company
Shandong Luoxin Pharmaceutical
Shandong Luoxin Pharmaceutical
China - Linyi
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers